1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Dr. Chevalier has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Sankyo, Rottapharm, Expanscience, Pfizer, Genzyme, Servier, Fidia, and Negma.
2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Osteoarthritis
You have full text access to this OnlineOpen article
Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study†
Article first published online: 26 FEB 2009
DOI: 10.1002/art.24096
Copyright © 2009 by the American College of Rheumatology
Additional Information
How to Cite
Chevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D. and Appleton, B. E. (2009), Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study. Arthritis & Rheumatism, 61: 344–352. doi: 10.1002/art.24096
- †
ClinicalTrials.gov identifier: NCT00110916.
Publication History
- Issue published online: 26 FEB 2009
- Article first published online: 26 FEB 2009
- Manuscript Accepted: 6 NOV 2008
- Manuscript Received: 29 JUN 2008
Funded by
- Amgen
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254), Osteoarthritis and Cartilage, 2012, 20, 4, 271
- 2, , , , , Efficacy of Infliximab in a Rabbit Model of Osteoarthritis, Connective Tissue Research, 2012, 1
- 3, , , , Evidence-Based Knee Injections for the Management of Arthritis, Pain Medicine, 2012, 13, 5Direct Link:
- 4
- 5
- 6
- 7, , , , The osteoarthritic niche and modulation of skeletal stem cell function for regenerative medicine, Journal of Tissue Engineering and Regenerative Medicine, 2012, 6, 6Direct Link:
- You have free access to this content8, A clinical perspective of IL-1β as the gatekeeper of inflammation, European Journal of Immunology, 2011, 41, 5Direct Link:
- 9, , , , , , , , , , , A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee, Arthritis Research & Therapy, 2011, 13, 4, R125
- 10, Are we moving in the right direction with osteoarthritis drug discovery?, Expert Opinion on Therapeutic Targets, 2011, 15, 12, 1355
- 11, Autologous Biologic Treatment for Equine Musculoskeletal Injuries: Platelet-Rich Plasma and IL-1 Receptor Antagonist Protein, Veterinary Clinics of North America: Equine Practice, 2011, 27, 2, 275
- You have free access to this content12, Blocking interleukin-1β in acute and chronic autoinflammatory diseases, Journal of Internal Medicine, 2011, 269, 1Direct Link:
- 13, , , Blood-derived anti-inflammatory protein solution blocks the effect of IL-1β on human macrophages in vitro, Inflammation Research, 2011, 60, 10, 929
- 14, , , Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy, Arthritis Research & Therapy, 2011, 13, 4, 124
- 15, , , , Effect of Intra-Articular Administration of Interleukin 1 Receptor Antagonist on Cartilage Repair in Temporomandibular Joint, Journal of Craniofacial Surgery, 2011, 22, 2, 711
- 16
- 17
- 18, , , , , , , , , Gait and behavior in an IL1β-mediated model of rat knee arthritis and effects of an IL1 antagonist, Journal of Orthopaedic Research, 2011, 29, 5Direct Link:
- 19, , , , , , , Glatiramer acetate (GA), the immunomodulatory drug, inhibits inflammatory mediators and collagen degradation in osteoarthritis (OA) cartilage, Osteoarthritis and Cartilage, 2011, 19, 9, 1158
- 20, , , , In vitro inhibition of compression-induced catabolic gene expression in meniscal explants following treatment with IL-1 receptor antagonist, Journal of Orthopaedic Science, 2011, 16, 2, 212
- 21, , , , , , Inhibition of the IL-1β-induced Expression of Matrix Metalloproteinases by Controlled Release of IL-1 Receptor Antagonist Using Injectable and Thermo-reversible Gels in Human Osteoarthritis Chondrocytes, Journal of Rheumatic Diseases, 2011, 18, 2, 85
- 22, Interleukin-1 in the pathogenesis and treatment of inflammatory diseases, Blood, 2011, 117, 14, 3720
- 23, , L’arthrose : une nouvelle maladie inflammatoire ? Actualités fondamentales et thérapeutiques, Médecine & Longévité, 2011, 3, 3, 116
- 24, , , , , Temporal expression and tissue distribution of interleukin-1β in two strains of guinea pigs with varying propensity for spontaneous knee osteoarthritis, Osteoarthritis and Cartilage, 2011, 19, 4, 439
- 25, , , , , , , The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, 2011, 50, 7, 1341
- 26, , , , , , , The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors, Arthritis Research & Therapy, 2011, 13, 2, R50
- 27
- 28
- 29
- 30
- 31, Évolution de la prise en charge pharmacologique de l’arthrose : les biothérapies, La Presse Médicale, 2010, 39, 11, 1164
- 32, , , , Cartilage biology, pathology, and repair, Cellular and Molecular Life Sciences, 2010, 67, 24, 4197
- 33, , , Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi, Equine Veterinary Journal, 2010, 42, 8Direct Link:
- 34, , , , Experimental models of osteoarthritis: usefulness in the development of disease-modifying osteoarthritis drugs/agents, Therapy, 2010, 7, 6, 621
- 35, , , Osteoarthritis: can anti-cytokine therapy play a role in treatment?, Clinical Rheumatology, 2010, 29, 5, 451
- 36, , , Proteomics of osteoarthritic chondrocytes and cartilage, Expert Review of Proteomics, 2010, 7, 5, 749
- 37
- 38, , , , , Role of proinflammatory cytokines in the pathophysiology of osteoarthritis, Nature Reviews Rheumatology, 2010, 7, 1, 33
- 39
- 40, Targeted therapies in osteoarthritis: a systematic review of the trials on www.clinicaltrials.gov, Best Practice & Research Clinical Rheumatology, 2010, 24, 1, 107
- 41, , , , , , The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis, Arthritis & Rheumatism, 2010, 62, 3Direct Link:
- 42, , The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis, Nature Reviews Rheumatology, 2010, 6, 11, 625
- 43, , Treatment of knee osteoarthritis with Orthokine®-derived autologous conditioned serum, Expert Review of Clinical Immunology, 2010, 6, 3, 335
- 44, Why not treat human cancer with interleukin-1 blockade?, Cancer and Metastasis Reviews, 2010, 29, 2, 317
- 45, , Osteoarthritis: A single injection of anakinra for treating knee OA?, Nature Reviews Rheumatology, 2009, 5, 7, 363
- 46, , , , , , , , , , , , , , , , , , , , , Adverse effects of biologics: a network meta-analysis and Cochrane overview, The Cochrane Library,Direct Link: